drugset / Trial / NCT01167699
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The main objective of the study is to evaluate the patient preference for pain treatment with respect to quality of life in patients with moderate to severe non malignant pain. Patients who have insufficient pain relief and/or unacceptable side effects with the previous analgesic treatment WHO step 1 or 2 and require around-the-clock opioid therapy can be included in the study. The WHO step I or II analgesics will be compared with the new study medication OXN (oxycodone/naloxone).
Timeline
- Start
- 2009-06
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naloxone | Small molecule | — | — |
| Subject | Oxycodone | Other / unclassified | — | — |
Indications
No indication recorded.